Eva Bengtsson
61 – 70 of 75
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Tumor necrosis factor-alpha does not mediate diabetes-induced vascular inflammation in mice.
(
- Contribution to journal › Article
- 2008
-
Mark
Cystatin C and cathepsins in cardiovascular disease.
(
- Contribution to journal › Article
-
Mark
Elastin- and Collagen-Rich Human Carotid Plaques Have Increased Levels of the Cysteine Protease Inhibitor Cystatin C.
(
- Contribution to journal › Article
-
Mark
Inflammation and immunity in diabetic vascular complications.
(
- Contribution to journal › Article
- 2006
-
Mark
Chondroitin sulfate perlecan enhances collagen fibril formation - Implications for perlecan chondrodysplasias
(
- Contribution to journal › Article
- 2005
-
Mark
Absence of the protease inhibitor cystatin C in inflammatory cells results in larger plaque area in plaque regression of apoE-deficient mice.
(
- Contribution to journal › Article
-
Mark
Lack of the Cysteine-Protease Inhibitor Cystatin C Promotes Atherosclerosis in Apolipoprotein E-Deficient Mice.
(
- Contribution to journal › Article
- 2004
-
Mark
Inhibition of Tumor Necrosis Factor-{alpha} Reduces Atherosclerosis in Apolipoprotein E Knockout Mice.
(
- Contribution to journal › Article
- 2002
-
Mark
The leucine-rich repeat protein PRELP binds perlecan and collagens and may function as a basement anchor.
(
- Contribution to journal › Article
- 1999
-
Mark
Structure and Interactions of the Extracellular Matrix Protein PRELP
1999)(
- Thesis › Doctoral thesis (compilation)